相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias
Bella S. Guerrouahen et al.
CLINICAL CANCER RESEARCH (2010)
FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation
Goichi Yoshimoto et al.
BLOOD (2009)
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation
Stephan Metzelder et al.
BLOOD (2009)
Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis
Paola Secchiero et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells
Paola Secchiero et al.
CURRENT DRUG METABOLISM (2007)
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825
Tri K. Nguyen et al.
BLOOD (2007)
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes
D Campioni et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)